NBO Pharma Inc.

New Filing
CIK: 0002103906·Pharmaceuticals·DELAWARE·Filed: Nov 9, 2026
Total Offering

$7,000,000

Amount Sold

$238,000

Investors

5

First Sale

Nov 2, 2026

Offering Details

Type
Equity, Option to Acquire
Exemptions
Rule 506(c)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Fredric David Price
Related Person
Robert Friedman
Related Person
Colin Foster
Related Person
Bard Geesaman
Related Person

Company

NBO Pharma Inc.

64 QUARRY LANE

BEDFORD, NY, 10506

914-645-1130

SEC Filing

0002103906-26-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free